The Role of Pharmacological Treatment in the Chemoreflex Modulation

Front Physiol. 2022 Jun 14:13:912616. doi: 10.3389/fphys.2022.912616. eCollection 2022.

Abstract

From a physiological point of view, peripheral chemoreceptors (PCh) are the main sensors of hypoxia in mammals and are responsible for adaptation to hypoxic conditions. Their stimulation causes hyperventilation-to increase oxygen uptake and increases sympathetic output in order to counteract hypoxia-induced vasodilatation and redistribute the oxygenated blood to critical organs. While this reaction promotes survival in acute settings it may be devastating when long-lasting. The permanent overfunctionality of PCh is one of the etiologic factors and is responsible for the progression of sympathetically-mediated diseases. Thus, the deactivation of PCh has been proposed as a treatment method for these disorders. We review here physiological background and current knowledge regarding the influence of widely prescribed medications on PCh acute and tonic activities.

Keywords: chemoreceptors sensitivity; chemoreceptors tonicity; chemoreflex; medications; peripheral chemoreceptors; pharmacotherapy.

Publication types

  • Review

Grants and funding

This research was financially supported from the National Science Center Poland (NCN) grant no 2017/27/N/NZ4/02863.